4.5 Article

Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 25, Issue 3, Pages 879-887

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.25.3.879-887.2005

Keywords

-

Funding

  1. NHLBI NIH HHS [R01 HL 45565, R01 HL045565] Funding Source: Medline
  2. NIAMS NIH HHS [R01 AR045653, R01 AR 45653] Funding Source: Medline

Ask authors/readers for more resources

ETR-3 (also know as BRUNOL3, NAPOR, and CUGBP2) is one of six members of the CELF (CUG-BP1- and ETR-3-like factor) family of splicing regulators. ETR-3 regulates splicing by direct binding to the pre-mRNA. We performed systematic evolution of ligands by exponential enrichment (SELEX) to identify the preferred binding sequence of ETR-3. After five rounds of SELEX, ETR-3 selected UG-rich sequences. in particular UG repeats and UGUU motifs. Either of these selected motifs was able to restore ETR-3 binding and responsiveness to a nonresponsive splicing reporter in vivo. Moreover, this effect was not specific to ETR-3 since minigenes containing either of the two motifs were responsive to two other CELF proteins (CUG-BP1 and CELF4), indicating that different members of the CELF family can mediate their effects via a common binding site. Using the SELEX-identified motifs to search the human genome. we identified several possible new ETR-3 targets. We created minigenes for two of these genes, the CFTR and MTMR1 genes. and confirmed that ETR-3 regulates their splicing patterns. For the CFTR minigene this regulation was demonstrated to be dependent on the presence of the putative binding site identified in our screen. These results validate this approach to search for new targets for RNA processing proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available